Table 2.
Risk of ADHD treatment discontinuation during total follow-up (N = 13,489)
| Characteristics | Number | % Discontinued | Crude HR (95% CI) | Adjusted HR (95% CI)a |
|---|---|---|---|---|
| Time cohort | ||||
| Jan 2002–Dec 2002 | 1,458 | 78.9 | 1.00 (reference) | 1.00 (reference) |
| Jan 2003–June 2004 | 3,864 | 69.6 | 0.86 (0.81–0.91) | 0.98 (0.92–1.04) |
| July 2004–Dec 2005 | 3,248 | 53.4 | 0.70 (0.66–0.75) | 0.86 (0.81–0.92) |
| Sex | ||||
| Male | 5,907 | 60.3 | 1.00 (reference) | 1.00 (reference) |
| Female | 2,663 | 72.0 | 1.39 (1.32–1.45) | 1.09 (1.04–1.15) |
| Age category | ||||
| 0–5 years | 294 | 53.5 | 0.64 (0.57–0.72) | 0.67 (0.59–0.75) |
| 6–11 years | 2,910 | 48.8 | 0.52 (0.49–0.56) | 0.53 (0.50–0.56) |
| 12–17 years | 1,810 | 72.1 | 1.00 (reference) | 1.00 (reference) |
| 18–45 years | 3,556 | 79.7 | 1.37 (1.29–1.45) | 1.13 (1.06–1.19) |
aAdjusted for other characteristics in Table 2